4//SEC Filing
Rothbaum Wayne P. 4
Accession 0001144204-18-063613
CIK 0001425205other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:32 PM ET
Size
7.9 KB
Accession
0001144204-18-063613
Insider Transaction Report
Form 4
Rothbaum Wayne P.
Director
Transactions
- Purchase
Common Stock
2018-12-06$9.86/sh+300,000$2,958,000→ 7,067,333 total(indirect: By LLC) - Purchase
Common Stock
2018-12-04$10.31/sh+921,053$9,496,056→ 6,767,333 total(indirect: By LLC)
Footnotes (3)
- [F1]The price reported in Column 4 is an average price. These shares were purchased by Quogue Capital LLC in multiple transactions at prices ranging from $9.88 to $10.51, inclusive. The reporting person undertakes to provide to Iovance Biotherapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is an average price. These shares were purchased by Quogue Capital LLC in multiple transactions at prices ranging from $9.40 to $10.07, inclusive.
- [F3]The reporting person is the managing member of Quogue Capital LLC and so may be deemed to beneficially own such shares of common stock. The numbers reported in column 6 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock held by Quogue Capital LLC.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001423102
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:32 PM ET
- Size
- 7.9 KB